Janus Henderson Group
RETA

Janus Henderson Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Janus Henderson Group’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$107M Buy
2023
Q1 		$20.3M Buy
2022
Q4 		$204K Buy
2021
Q2 		– Sell
2021
Q1 		$7.17M Buy
2020
Q4 		$6.13M Buy